US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history. Read the full story

Pfizer and Hospira have entered into a definitive merger agreement under which Pfizer will acquire Hospira, the world’s leading provider of injectable drugs and infusion technologies and a global leader in biosimilars, Read the full story

M&A news: Luye Pharma of China will pay $599 million to acquire a 58% stake in Beijing Jialin Pharmaceutical Co., a company that makes drug products for cardiovascular diseases and cancer. Read the full story

Big Pharma, Valeant Pharmaceuticals International Team Up To Make $45.6 Billion Allergan Bid. Read the full story

Questcor Pharmaceuticals, a biopharmaceutical company, with headquarters in California, USA has announced about 6 deals since 2009. Analysis of the partnering deals shows a strong emphasis on deals announced in neurology, nephrology and rheumatology therapeutics areas. Read the full story

Vertex has announced only 1 M&A deal since 2009, with the acquisition of ViroChem. Read the full story

With over 450 deals announced, 2013 was a big year for mergers and acquisitions in the life sciences Read the full story

Shionogi has announced only 2 M&A deals since 2005, with the deals being the acquisition of C&O Pharmaceutical Technology and Sciele Pharma. Read the full story

Endo Pharmaceuticals is a top 50 pharma company specialising in brand pharmaceuticals for the treatment of pain, urology, oncology, CNS and derma products. Read the full story

Salix Pharmaceuticals acquires specialty pharma, Santarus for a whopping $2.6 billion cash transaction. Read the full story